Penserra Capital Management LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 87 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q2 2020$245,000
+528.2%
16,705
+415.1%
0.01%
+225.0%
Q4 2016$39,000
+30.0%
3,243
+24.3%
0.00%0.0%
Q3 2016$30,000
+114.3%
2,610
+66.7%
0.00%
+100.0%
Q2 2016$14,000
+180.0%
1,566
+53.5%
0.00%
Q1 2016$5,000
+25.0%
1,020
+86.1%
0.00%
Q4 2015$4,0005480.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders